![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 29, 30252-30258, July 16, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan 48109-0632
Like other nitric-oxide synthase (NOS) enzymes, neuronal NOS (nNOS) turnover and activity are regulated by the ubiquitous protein chaperone hsp90. We have shown previously that nNOS expressed in Sf9 cells where endogenous heme levels are low is activated from the apo- to the holo-enzyme by addition of exogenous heme to the culture medium, and this activation is inhibited by radicicol, a specific inhibitor of hsp90 (Billecke, S. S., Bender, A. T., Kanelakis, K. C., Murphy, P. J. M., Lowe, E. R., Kamada, Y., Pratt, W. B., and Osawa, Y. (2002) J. Biol. Chem. 278, 1546515468). In this work, we examine heme binding by apo-nNOS to form the active enzyme in a cell-free system. We show that cytosol from Sf9 cells facilitates heme-dependent apo-nNOS activation by promoting functional heme insertion into the enzyme. Sf9 cytosol also converts the glucocorticoid receptor (GR) to a state where the hydrophobic ligand binding cleft is open to access by steroid. Both cell-free heme activation of purified nNOS and activation of steroid binding activity of the immunopurified GR are inhibited by radicicol treatment of Sf9 cells prior to cytosol preparation, and addition of purified hsp90 to cytosol partially overcomes this inhibition. Although there is an hsp90-dependent machinery in Sf9 cytosol that facilitates heme binding by apo-nNOS, it is clearly different from the machinery that facilitates steroid binding by the GR. hsp90 regulation of apo-nNOS heme activation is very dynamic and requires higher concentrations of radicicol for its inhibition, whereas GR steroid binding is determined by assembly of stable GR·hsp90 heterocomplexes that are formed by a purified five-chaperone machinery that does not activate apo-nNOS.
Received for publication, April 7, 2004 , and in revised form, May 14, 2004.
* This work was supported by National Institutes of Health Grants ES08365 (to Y. O.) and DK31573 (to W. B. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Established Investigator of the American Heart Association. To whom correspondence should be addressed: Dept. of Pharmacology, The University of Michigan Medical School, 1301 Medical Science Research Bldg. III, Ann Arbor, MI 48109-0632. Tel.: 734-936-5797; Fax: 734-763-4450; E-mail: osawa{at}umich.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. B. Pratt, Y. Morishima, and Y. Osawa The Hsp90 Chaperone Machinery Regulates Signaling by Modulating Ligand Binding Clefts J. Biol. Chem., August 22, 2008; 283(34): 22885 - 22889. [Full Text] [PDF] |
||||
![]() |
A. Y. Dunbar, G. J. Jenkins, S. Jianmongkol, M. Nakatsuka, E. R. Lowe, M. Lau, and Y. Osawa Tetrahydrobiopterin Protects against Guanabenz-Mediated Inhibition of Neuronal Nitric-Oxide Synthase in Vitro and in Vivo Drug Metab. Dispos., September 1, 2006; 34(9): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Yetik-Anacak, T. Xia, C. Dimitropoulou, R. C. Venema, and J. D. Catravas Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H260 - H268. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. M. Murphy, Y. Morishima, J. J. Kovacs, T.-P. Yao, and W. B. Pratt Regulation of the Dynamics of hsp90 Action on the Glucocorticoid Receptor by Acetylation/Deacetylation of the Chaperone J. Biol. Chem., October 7, 2005; 280(40): 33792 - 33799. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-M. Peng, Y. Morishima, G. J. Jenkins, A. Y. Dunbar, M. Lau, C. Patterson, W. B. Pratt, and Y. Osawa Ubiquitylation of Neuronal Nitric-oxide Synthase by CHIP, a Chaperone-dependent E3 Ligase J. Biol. Chem., December 17, 2004; 279(51): 52970 - 52977. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |